BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank93
3Y CAGR+12.0%
5Y CAGR+31.7%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
+12.0%/yr
Annual compound
5Y CAGR
+31.7%/yr
Recent deceleration
Percentile
P93
Near historical high
vs 5Y Ago
4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 17.79% | -22.0% |
| 2024 | 22.79% | +79.8% |
| 2023 | 12.68% | +0.2% |
| 2022 | 12.66% | +392.8% |
| 2021 | 2.57% | -42.9% |
| 2020 | 4.50% | +140.1% |
| 2019 | 1.87% | +928.9% |
| 2018 | -0.23% | -103.3% |
| 2017 | 6.92% | +111.1% |
| 2016 | -62.50% | - |